podcastdetails.com

Share

OncoPharm

Inavolisib

Listen

Description

A new PIK3Ca inhibitor is approved for breast cancer.

Print Share

Want to check another podcast?

Enter the RSS feed of a podcast, and see all of their public statistics.

Made by Alex Barredo. Send your feedback to alex@barredo.es.